A Study to Assess the Safety and Efficacy of Nitric Oxide Injection Into Unresectable Solid Primary or Metastatic Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Greenberg, MD
Study Internal Medical Monitor
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Soroka Medical Center
Beersheba, Israel
Recruiting - Hadassah Ein-Karem
Jerusalem, Israel
Recruiting - Sheba Medical Center
Ramat Ef‘al, Israel
Recruiting - Sourasky Tel Aviv Medical Center
Tel Aviv, Israel
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Aug 2022
- Primary completion
- 30 May 2025
- Completion
- 30 Jun 2025
- Last update posted
- 16 Aug 2024
- Registered enrollment
- 38
- Registry id
- NCT05351502
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.